Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 128, Issue 1
July 7 2016
Issue Cover

Table of Contents

ANNIVERSARY EDITORIAL

Blood’s 70th anniversary: CARs on the Blood highway
Cynthia E. Dunbar
View Articletitled, <em>Blood</em>’s 70th anniversary: CARs on the <em>Blood</em> highway

BLOOD FLASHBACK

Fessas P, Stamatoyannopoulos G. Hereditary persistence of fetal hemoglobin in Greece: a study and a comparison. Blood. 1964;24(3):223-240.
View Articletitled, Fessas P, Stamatoyannopoulos G. Hereditary persistence of fetal hemoglobin in Greece: a study and a comparison. <em>Blood</em>. 1964;24(3):<span class="related-article">223-240</span>.

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
Gene therapy for PID: the end of the beginning?
Andrew R. Gennery
View Articletitled, Gene therapy for PID: the end of the beginning?
INSIDE BLOOD COMMENTARY
Just 1 test to diagnose AML?!!
Richard Dillon,David Grimwade
View Articletitled, Just 1 test to diagnose AML?!!
INSIDE BLOOD COMMENTARY
A new junctional hierarchy
Timothy J. Satchwell,Ashley M. Toye
View Articletitled, A new junctional hierarchy
INSIDE BLOOD COMMENTARY
Predicting relevant immunogenetic disparities
Joseph Pidala,Claudio Anasetti
View Articletitled, Predicting relevant immunogenetic disparities
INSIDE BLOOD COMMENTARY
IL-2, the next best thing in chronic GVHD therapy?
Lauren M. Curtis,Steven Z. Pavletic
View Articletitled, IL-2, the next best thing in chronic GVHD therapy?

PERSPECTIVES

Moving treatment-free remission into mainstream clinical practice in CML
Clinical Trials & Observations
Timothy P. Hughes,David M. Ross
View Articletitled, Moving treatment-free remission into mainstream clinical practice in CML

REVIEW ARTICLE

Metastasis: new functional implications of platelets and megakaryocytes
Raphael Leblanc,Olivier Peyruchaud
View Articletitled, Metastasis: new functional implications of platelets and megakaryocytes

EVIDENCE-BASED FOCUSED REVIEW

The role of whole brain radiation in primary CNS lymphoma
Clinical Trials & Observations
Benjamin Kasenda,Jay Loeffler,Gerald Illerhaus,Andrés J. M. Ferreri,James Rubenstein,Tracy T. Batchelor
View Articletitled, The role of whole brain radiation in primary CNS lymphoma

CLINICAL TRIALS AND OBSERVATIONS

Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma
Clinical Trials & Observations
Saad Z. Usmani,Brendan M. Weiss,Torben Plesner,Nizar J. Bahlis,Andrew Belch,Sagar Lonial,Henk M. Lokhorst,Peter M. Voorhees,Paul G. Richardson,Ajai Chari,A. Kate Sasser,Amy Axel,Huaibao Feng,Clarissa M. Uhlar,Jianping Wang,Imran Khan,Tahamtan Ahmadi,Hareth Nahi
View Articletitled, Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma
Supplemental data

GENE THERAPY

Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency
Maria Pia Cicalese,Francesca Ferrua,Laura Castagnaro,Roberta Pajno,Federica Barzaghi,Stefania Giannelli,Francesca Dionisio,Immacolata Brigida,Marco Bonopane,Miriam Casiraghi,Antonella Tabucchi,Filippo Carlucci,Eyal Grunebaum,Mehdi Adeli,Robbert G. Bredius,Jennifer M. Puck,Polina Stepensky,Ilhan Tezcan,Katie Rolfe,Erika De Boever,Rickey R. Reinhardt,Jonathan Appleby,Fabio Ciceri,Maria Grazia Roncarolo,Alessandro Aiuti
View Articletitled, Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency
Supplemental data

HEMATOPOIESIS AND STEM CELLS

Conditional knockout mice demonstrate function of Klf5 as a myeloid transcription factor
Brief Report
Nur Hezrin Shahrin,Sonya Diakiw,Lindsay A. Dent,Anna L. Brown,Richard J. D’Andrea
View Articletitled, Conditional knockout mice demonstrate function of Klf5 as a myeloid transcription factor
Supplemental data

IMMUNOBIOLOGY

Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice
Sophia Maschalidi,Fernando E. Sepulveda,Alexandrine Garrigue,Alain Fischer,Geneviève de Saint Basile
View Articletitled, Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice
Supplemental data

LYMPHOID NEOPLASIA

TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses
Clinical Trials & Observations
Eleni Kotsiou,Jessica Okosun,Caroline Besley,Sameena Iqbal,Janet Matthews,Jude Fitzgibbon,John G. Gribben,Jeffrey K. Davies
View Articletitled, <em>TNFRSF14</em> aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses
Supplemental data
Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma
Nakhle S. Saba,Delong Liu,Sarah E. M. Herman,Chingiz Underbayev,Xin Tian,David Behrend,Marc A. Weniger,Martin Skarzynski,Jennifer Gyamfi,Lorena Fontan,Ari Melnick,Cliona Grant,Mark Roschewski,Alba Navarro,Sílvia Beà,Stefania Pittaluga,Kieron Dunleavy,Wyndham H. Wilson,Adrian Wiestner
View Articletitled, Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma
Supplemental data

MYELOID NEOPLASIA

Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies
e-blood
Thomas McKerrell,Thaidy Moreno,Hannes Ponstingl,Niccolo Bolli,João M. L. Dias,German Tischler,Vincenza Colonna,Bridget Manasse,Anthony Bench,David Bloxham,Bram Herman,Danielle Fletcher,Naomi Park,Michael A. Quail,Nicla Manes,Clare Hodkinson,Joanna Baxter,Jorge Sierra,Theodora Foukaneli,Alan J. Warren,Jianxiang Chi,Paul Costeas,Roland Rad,Brian Huntly,Carolyn Grove,Zemin Ning,Chris Tyler-Smith,Ignacio Varela,Mike Scott,Josep Nomdedeu,Ville Mustonen,George S. Vassiliou
View Articletitled, Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Gene disruption of dematin causes precipitous loss of erythrocyte membrane stability and severe hemolytic anemia
Yunzhe Lu,Toshihiko Hanada,Yuko Fujiwara,Jennifer O. Nwankwo,Adam J. Wieschhaus,John Hartwig,Sha Huang,Jongyoon Han,Athar H. Chishti
View Articletitled, Gene disruption of dematin causes precipitous loss of erythrocyte membrane stability and severe hemolytic anemia
Supplemental data

THROMBOSIS AND HEMOSTASIS

Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo
Junliang Pan,Thanh Theresa Dinh,Anusha Rajaraman,Mike Lee,Alexander Scholz,Cathrin J. Czupalla,Helena Kiefel,Li Zhu,Lijun Xia,John Morser,Haiyan Jiang,Laura Santambrogio,Eugene C. Butcher
View Articletitled, Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo
Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP
Vikram G. Pillai,Jialing Bao,Catherine B. Zander,Jenny K. McDaniel,Palaniappan S. Chetty,Steven H. Seeholzer,Khalil Bdeir,Douglas B. Cines,X. Long Zheng
View Articletitled, Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP

TRANSPLANTATION

Functional distance between recipient and donor HLA-DPB1 determines nonpermissive mismatches in unrelated HCT
Pietro Crivello,Andreas Heinold,Vera Rebmann,Hellmut D. Ottinger,Peter A. Horn,Dietrich W. Beelen,Katharina Fleischhauer
View Articletitled, Functional distance between recipient and donor HLA-DPB1 determines nonpermissive mismatches in unrelated HCT
Supplemental data
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
Clinical Trials & Observations
John Koreth,Haesook T. Kim,Kyle T. Jones,Paulina B. Lange,Carol G. Reynolds,Marie J. Chammas,Katherine Dusenbury,Jennifer Whangbo,Sarah Nikiforow,Edwin P. Alyea, III,Philippe Armand,Corey S. Cutler,Vincent T. Ho,Yi-Bin Chen,David Avigan,Bruce R. Blazar,Joseph H. Antin,Jerome Ritz,Robert J. Soiffer
View Articletitled, Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
Supplemental data

LETTERS TO BLOOD

The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis
Clinical Trials & Observations
Darryl P. Leong,François Caron,Christopher Hillis,Annie Duan,Jeff S. Healey,Graeme Fraser,Deborah Siegal
View Articletitled, The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis
No TP63 rearrangements in a selected group of primary cutaneous CD30+ lymphoproliferative disorders with aggressive clinical course
Clinical Trials & Observations
Anne M. R. Schrader,Yan-Yi Chung,Patty M. Jansen,Karoly Szuhai,Armando N. Bastidas Torres,Cornelis P. Tensen,Rein Willemze
View Articletitled, No <em>TP63</em> rearrangements in a selected group of primary cutaneous CD30<sup>+</sup> lymphoproliferative disorders with aggressive clinical course
LNK mutations in familial myeloproliferative neoplasms
Elisa Rumi,Ashot S. Harutyunyan,Daniela Pietra,Jelena D. Milosevic Feenstra,Chiara Cavalloni,Elisa Roncoroni,Ilaria Casetti,Marta Bellini,Chiara Milanesi,Maria C. Renna,Manuel Gotti,Cesare Astori,Robert Kralovics,Mario Cazzola
View Articletitled, <em>LNK</em> mutations in familial myeloproliferative neoplasms

BLOOD WORK

Chronic myelogenous leukemia evolving after treatment of multiple myeloma
Denise Wolleschak,Florian H. Heidel
View Articletitled, Chronic myelogenous leukemia evolving after treatment of multiple myeloma
All Issues

Advertisement intended for health care professionals

Time for a new prognostic score in CLL?
Azab AK, Runnels JM, Pitsillides C, et al. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood. 2009;113(18):4341-4351.
Garcia E, Horowitz AM, Franklin K, Mader M, Kaur S. Outcomes of veterans with FMS-like tyrosine kinase 3 mutated (mFLT3) acute myeloid leukemia (AML) treated with novel FLT3 inhibitors (FLT3i) within the Veterans Health Administration (VHA) [abstract]. Blood. 2023;142(suppl 1):7414.
Soluble Glycoprotein VI Predicts Abdominal Aortic Aneurysm Growth Rate and is a Novel Therapeutic Target
Murine models of erythroid 5ALA synthesis disorders and their conditional synthetic lethal dependency on pyridoxine

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals